Ada Investment Management’s Kite Pharma, Inc. KITE Stock Holding History

Ada Investment Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$294K	Buy	+4,775	New	+$336K	0.2%	207

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ada Investment Management's KITE Position: Q4 2015 in Review

Ada Investment Management opened a new position in Kite Pharma, Inc. (KITE) in Q4 2015: 4,775 shares worth $294K. The stake represents 0.2% of the portfolio and ranks #207 among its holdings.

187 funds tracked by Wall St. Rank hold KITE as of Q4 2015.

Ada Investment Management held 4,775 shares of Kite Pharma, Inc. worth $294K as of Q4 2015.
Kite Pharma, Inc. was a new Ada Investment Management position in Q4 2015.
Kite Pharma, Inc. made up 0.2% of Ada Investment Management's portfolio in Q4 2015, its #207 holding.
187 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2015.

Based on Ada Investment Management's 13F filing for Q4 2015, filed 19 Feb 2016.